Latest Blog Posts Tagged "Research News"
August 24, 2016
To keep you informed of the Foundation's research investments, we're highlighting a few newly funded grants supporting the development of therapies to address common non-motor symptoms of Parkinson's.
August 23, 2016
A recent editorial from MJFF and J. William Langston, MD, outlines a strategy to develop targeted treatments that could prevent, slow or stop Parkinson's progression.
August 16, 2016
Cynapsus Therapeutics Inc. announced results from the Phase II trial of their under-the-tongue strip that can alleviate motor symptoms; the therapy is now in Phase III testing.
July 26, 2016
Last month scientists and physicians from around the world gathered at the International Congress of Parkinson's Disease and Movement Disorders to discuss emerging trends in care and research.
July 25, 2016
The Michael J. Fox Foundation today announced the expansion of Fox Trial Finder, an online research matching tool, to include studies on atypical parkinsonism.
July 21, 2016
A recent study led by Dr. J. Timothy Greenamyre, a member of our scientific advisory board, sheds new light on the connection between alpha-synuclein and the degeneration of cells in Parkinson's.
July 12, 2016
Today MJFF, the Van Andel Research Institute and the Cure Parkinson's Trust announced plans to collaborate to assess the clinical use and development of cancer drug nilotinib.
June 27, 2016
The Safety of Urate Elevation in Parkinson's Disease Phase III study (SURE-PD3) is in the final stage of clinical testing.
June 17, 2016
Discovery of this gene provides a new potential therapeutic target for PD treatment.
June 13, 2016
Today the Foundation announced a $2 million prize to motivate the research field to develop an imaging tracer to visualize alpha-synuclein in the brain and help test therapies to slow or stop disease.